These L cells release glucagon-like peptides that directly act on hepatocytes by activating genes involved in fatty acid β-oxidation and insulin sensitivity which are both closely linked to NAFLD [53]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.